Investors of micro-cap biotech Capricor (CAPR) were probably raising a glass or two last week, as the stock skyrocketed by 253% in one …
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section.
Capricor Therapeutics Inc (NASDAQ:CAPR) reported its fourth quarter and full year 2017 financial results. It also provided a corporate update.
Brace yourself. Capricor Therapeutics Inc (NASDAQ:CAPR) is on the move.
US-based biotechnology firm Capricor Therapeutics Inc (NASDAQ:CAPR) announced that the American Heart Association (AHA) Scientific Sessions 2017 has accepted for presentation at a late-breaking session the …
Analyst spotlights a compelling path forward for DMD program and looks to key catalysts in fourth quarter.
On Tuesday, Capricor Therapeutics, Inc. (NASDAQ:CAPR) was granted FDA Rare Pediatric Disease Designation for CAP-1002, the company’s treatment for Duchenne muscular dystrophy (DMD) and …
Netflix, Inc. (NASDAQ:NFLX) shares are shooting up in Tuesday’s trading session following the release of very impressive earnings results for the second quarter.
It’s a very rewarding trading day for investors in Capricor Therapeutics Inc (NASDAQ:CAPR) with shares up nearly 130%, making the stock Wall Street’s …
In a research note issued today, H.C.
